Pharmafile Logo
Pharmafocus logo
Advanced Search
Valeant logo

Valeant announces strong Q3 results, will expand US contact lens plant

October 20, 2015
Manufacturing and Production, Sales and Marketing Valeant, financial results, manufacturing, production

Valeant has announced plans to invest up to $150 million and add 200 jobs at its Bausch and Lomb plant …

News
Sprout sign

‘Female Viagra’ goes on sale in the US

October 20, 2015
Addyi, HSDD, Sprout, female viagra, flibanserin, hypoactive sexual desire disorder

The pill dubbed the female version of Viagra – Sprout Pharmaceuticals’ Addyi – has gone on sale in the US. …

News
Daiichi Sankyo

Daiichi sheds more US jobs as generic losses take their toll

October 20, 2015
Daiichi, Daiichi Sankyo, generic competition, generics, job losses, patent cliff, patents, redundancies

The Japan-based drugmaker Daiichi Sankyo is to cut up to 1,200 jobs – or about half its workforce – in …

News
dominaix_scientist

Domainex and Imperial College London partner on heart attack treatments

October 20, 2015
Research and Development Domainex cardiac arrest

Drug discovery company Domainex and Imperial College London have announced a new partnership aimed at discovering novel therapies to treat …

News

Synergy Vision expands global presence to meet demand in the Asia-Pacific region

October 20, 2015
Medical Communications Asia-Pacific, Australia, Sydney, Synergy Vision, asia pacific, medical communcations

UK-based Synergy Vision opens a new office in Sydney, Australia, to meet the demands of their clients across the Asia-Pacific …

News
Press release

Recall after mislabelling of Medline Industries’ drugs

October 20, 2015
Manufacturing and Production US, acetaminophen, paracetamol, product recall

Medline Industries is voluntarily carrying out a nationwide recall of the painkiller acetaminophen, due to a labelling error on the …

News
China manufacturing

China’s Tianjin invests $300m in Ebola plant

October 20, 2015
Manufacturing and Production China, Ebola, Ebola vaccine, manufacturing, production, vaccines

China’s Tianjin CanSino Biotechnology, a developer of affordable vaccines, says that it will invest 2 billion Yuan (£203.3 million) in …

News
DNA

UK ‘is the best place in the world to do big data’, says AAR lead

October 20, 2015
Manufacturing and Production Accelerated Access Review, Big Data, Professor Sir John Bell

The UK is leading the world in developing new drugs from the analysis of big data, according to a leading …

News
nuevolution_logo

Nuevolution, Johnson & Johnson begin discovery collaboration

October 19, 2015
Manufacturing and Production, Research and Development Chemetics, Janssen Biotech, Nuevolution

Nuevolution and Janssen Biotech have entered into a collaboration which will use Nuevolution’s Chemetics drug discovery platform to facilitate discovery …

News
regeneron

Regeneron to invest $350 million, create 200 jobs in Ireland

October 19, 2015
Manufacturing and Production, Research and Development

US pharma company Regeneron has announced plans to invest $350 million into its production facility in Limerick, Ireland, creating 200 …

News
Allergan

2015’s top five mergers and acquisitions in a record-breaking year

October 19, 2015
Sales and Marketing Deals, acquisitions, mergers, pharma, takeovers

A new report from analysts MergerMarket reveals that mergers and acquisitions so far in 2015 have surpassed the same 2014 …

Feature
Flemming Ornskov

Shire’s dry eye treatment gets a no – for now

October 19, 2015
Sales and Marketing Complete Response Letter, FDA, Flemming Ornskov, Shire, dry eye disease, lifitegrast

Shire has seen an application for its dry eye treatment lifitegrast rejected by the US regulator. The FDA says it …

News
BI building at night

FDA approves Boehringer’s Pradaxa reversal agent

October 19, 2015
Sales and Marketing Boehringer Ingelheim, FDA, Pradaxa, Praxbind, anticoagulant, idarucizumab

The FDA has approved Boehringer Ingelheim’s Praxbind, a reversal agent for its anticoagulant Pradaxa. The US regulator approved Praxbind (idarucizumab) …

News
Praluent

Sanofi and Regeneron heart drug Praluent available in UK

October 19, 2015
Sales and Marketing Regeneron, Sanofi, alicrocumab, high cholesterol, praluent

Sanofi and Regeneron’s next-generation cholesterol-lowering treatment Praluent is now available for adult patients with high cholesterol in the UK, following …

News
onglyza

FDA rejects AstraZeneca diabetes combination

October 16, 2015
Research and Development, Sales and Marketing AstraZeneca, FDA, NDA, dapagliflozin, saxagliptin

The FDA has declined to approve AstraZeneca’s New Drug Application (NDA) for the investigational fixed-dose combination of Onglyza and and …

News
pfizer_logo

Pfizer’s Xeljanz denied plaque psoriasis indication by FDA

October 16, 2015
Research and Development, Sales and Marketing FDA, Pfizer, Xeljanj, tofacitinib

The FDA has rejected the indication expansion of Pfizer’s Xeljanz (tofacitinib) for treatment of moderate to severe cases of plaque psoriasis. …

News
abbvies_humira_cost_the_most_to_market_in_the_us_last_month

Top 10 US pharma advertising spenders, September 2015

October 16, 2015
Medical Communications, Sales and Marketing

 As a new study from TV advertising metrics company iSpot reveals the top 40 pharma companies spent $231 million on TV …

Feature

NICE to recommend three new treatments for hep C

October 16, 2015
Medical Communications AbbVie, BMS, Bristol-Myers Squibb, Exviera, Gilead, NICE, Viekirax, daklinza, harvoni, hepatitis C

NICE has recommended Bristol-Myers Squibb’s Daklinza, Gilead’s Harvoni and AbbVie’s Viekirax, with or without Exviera, as treatments for some adults …

News
david_tweedale_and_ian_robinson

Ashfield UK makes two new business development appointments for its growing team

October 16, 2015
Medical Communications Ashfield UK

Ashfield has appointed David Tweedale and Ian Robinson as Business Development Managers to the UK Commercial and Clinical business, located …

Appointment
david_mustalish

The Prime Medical Group expands senior team in New York City

October 16, 2015
Medical Communications

The Prime Medical Group is pleased to announce several key appointments to its New York office as the company continues …

Appointment
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026